| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 22,051 | 11,026 | 11,025 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| FARALLON CAPITAL | AT COST | 205,136 | 200,306 |
| CHARLES SCHWAB | AT COST | 26,202,090 | 28,720,932 |
| THOROFARE ASSET BASED LENDING FUND IV LP | AT COST | 33,166 | 33,166 |
| THOROFARE ASSET BASED LENDING FUND V LP | AT COST | 1,526,812 | 1,557,059 |
| BBR SERIES J | AT COST | 783,702 | 961,253 |
| PFM BIOTECH OPPORTUNITIES LP | AT COST | 985,132 | 960,204 |
| C&S SPEKTRIX, LLC | AT COST | 1,002,513 | 1,002,513 |
| PANTHEUM FEEDER FUND LIMITED | AT COST | 1,000,000 | 1,093,914 |
| COREVIEW OFFSHORE FUND LIMITED | AT COST | 1,000,000 | 640,069 |
| BBR LONG/SHORT - CLASS C | AT COST | 299,818 | 195,662 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| LICENSE FEE | 60 | 30 | 30 | |
| INVESTMENT FEES | 139,812 | 139,812 | 0 | |
| FILING FEES | 25 | 13 | 12 | |
| FEDERAL PENALTIES | 105 | 53 | 52 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| FROM K-1: FARALLON | 3,106 | 3,106 | 0 |
| FROM K-1: THOROFARE LENDING IV | -1,365 | -1,365 | 0 |
| FROM K-1: THOROFARE LENDING V | -2,265 | -2,265 | 0 |
| FROM K-1: BBR PRIVATE INVESTMENT FUND - SERIES J | 4,599 | 4,599 | 0 |
| FROM K-1: BBR FIXED INCOME OPPORTUNITIES FUND | -13,746 | -13,746 | 0 |
| FROM K-1: PFM BIOTECH OPPORTUNITIES LP | -17,439 | -17,439 | 0 |
| FROM K-1: C&S SPEKTRIX, LLC | -9,362 | -9,362 | 0 |
| Description | Amount |
|---|---|
| BOOK/TAX DIFFERENCES | 811,762 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| FEDERAL EXCISE TAX BASED ON INVESTMENT INCOME | 36,902 | 0 | 36,902 |